# Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

> **NCT00002543** · PHASE1 · COMPLETED · sponsor: **Medical College of Wisconsin** · enrollment: 3 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors
- Lymphoma
- Neuroblastoma
- Sarcoma
- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** gallium nitrate

## Key facts

- **NCT ID:** NCT00002543
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-02
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2013-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002543, "Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*